The high expression of LEDGF/p75 in relapsed AML may therefore protect against apoptosis both by stimulating the transcription of other survival genes and by partially blocking the effect of pro-apoptotic shorter versions of LEDGF/p75 and p52. Here, PSIP1 is linked to acute myeloid leukemia.